Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
25
SHPH Quote, Financials, Valuation and Earnings
Last price:
$1.96
Seasonality move
:
-36.33%
Day range:
$1.85 - $2.08
52-week range:
$1.26 - $25.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
16.07x
Volume:
174.5K
Avg. volume:
318.6K
1-year change:
-91.25%
Market cap:
$22.4M
Revenue:
--
EPS (TTM):
-$14.45
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Shuttle Pharmaceuticals Holdings, Inc. has -- downside to fair value with a price target of -- per share.
SHPH vs. S&P 500
-
Over the past 5 trading days, Shuttle Pharmaceuticals Holdings, Inc. has overperformed the S&P 500 by 8.2% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Shuttle Pharmaceuticals Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Shuttle Pharmaceuticals Holdings, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Shuttle Pharmaceuticals Holdings, Inc. reported revenues of --.
Earnings Growth
-
Shuttle Pharmaceuticals Holdings, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Shuttle Pharmaceuticals Holdings, Inc. reported earnings per share of -$1.05.
Enterprise value:
21M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.87x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$3.8K
Return On Assets:
-305.21%
Net Income Margin (TTM):
--
Return On Equity:
-697.07%
Return On Invested Capital:
-449.76%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$22.2K | -$5.7K | -$3.8K | -$800 | -$1K | |
| Operating Income | -$5.4M | -$7.2M | -$10.9M | -$3.1M | -$2.3M | |
| EBITDA | -$5.3M | -$7.2M | -$10.9M | -$3.1M | -$2.3M | |
| Diluted EPS | -$32.60 | -$4.20 | -$14.45 | -$1.59 | -$1.05 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $9.3M | $7M | $259.7K | $3.3M | |
| Total Assets | -- | $9.4M | $7.4M | $673.6K | $3.5M | |
| Current Liabilities | -- | $970.5K | $810.4K | $1.7M | $2M | |
| Total Liabilities | -- | $977.1K | $1.8M | $2M | $2.1M | |
| Total Equity | -- | $8.4M | $5.6M | -$1.3M | $1.4M | |
| Total Debt | -- | $6.7K | $905.6K | $505.6K | $175.3K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$5.2M | -$5.7M | -$11.2M | -$2M | -$2.6M | |
| Cash From Investing | -$2.9M | $3M | -- | $1.7M | -- | |
| Cash From Financing | $2.9M | -$1M | $13.1M | -$196.8K | -$96.4K | |
| Free Cash Flow | -$5.2M | -$5.7M | -$11.2M | -$2M | -$2.6M | |
SHPH
Sector
Market Cap
$22.4M
$28.1M
Price % of 52-Week High
8.08%
50.9%
Dividend Yield
0%
0%
Shareholder Yield
-32.27%
-1.55%
1-Year Price Total Return
-91.25%
-19.36%
Beta (5-Year)
--
0.498
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.82
200-day SMA
Sell
Level
$4.33
Bollinger Bands (100)
Sell
Level
1.97 - 3.89
Chaikin Money Flow
Buy
Level
191.2K
20-day SMA
Buy
Level
$1.76
Relative Strength Index (RSI14)
Buy
Level
56.09
ADX Line
Buy
Level
20.75
Williams %R
Neutral
Level
-35.7143
50-day SMA
Sell
Level
$2.11
MACD (12, 26)
Buy
Level
0.50
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Neutral
Level
495.4K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.1044)
Sell
CA Score
(Annual)
Level (-8.3789)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (18.3611)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.
Stock Forecast FAQ
In the current month, SHPH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SHPH average analyst price target in the past 3 months is --.
-
Where Will Shuttle Pharmaceuticals Holdings, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Shuttle Pharmaceuticals Holdings, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Shuttle Pharmaceuticals Holdings, Inc.?
Analysts are divided on their view about Shuttle Pharmaceuticals Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Shuttle Pharmaceuticals Holdings, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Shuttle Pharmaceuticals Holdings, Inc.'s Price Target?
The price target for Shuttle Pharmaceuticals Holdings, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SHPH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Shuttle Pharmaceuticals Holdings, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SHPH?
You can purchase shares of Shuttle Pharmaceuticals Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Shuttle Pharmaceuticals Holdings, Inc. shares.
-
What Is The Shuttle Pharmaceuticals Holdings, Inc. Share Price Today?
Shuttle Pharmaceuticals Holdings, Inc. was last trading at $1.96 per share. This represents the most recent stock quote for Shuttle Pharmaceuticals Holdings, Inc.. Yesterday, Shuttle Pharmaceuticals Holdings, Inc. closed at $2.04 per share.
-
How To Buy Shuttle Pharmaceuticals Holdings, Inc. Stock Online?
In order to purchase Shuttle Pharmaceuticals Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SHPH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SHPH
Sector
P/E ratio
--
24.09x
PEG ratio
0.00x
-0.01x
P/B ratio
16.07x
1.83x
Price / LTM sales
--
1.59x
Growth Metrics
SHPH
Sector
Revenue growth
--
4.68%
Earnings growth
33.79%
10.88%
Revenue (5-year growth)
--
6.45%
Earnings forecast
--
-$0.18
Profitability
SHPH
Sector
Profitability FY 2024
-$5.5K
$3.6M
Return on invested capital
-449.76%
-31.87%
Return on assets
-305.21%
-28.18%
Return on equity
-697.07%
-37.89%
Earnings Date
Last Earnings Date
Jan
7
Next Earnings Date
Jan
7
Estimated Next Earnings Date
Apr
8
Balance Sheet
SHPH
Sector
Total cash
$2.1M
$26.2M
Short term investments
--
$25.7M
Total assets
$2.5M
$76.7M
Long term debt
$175.3K
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
RGC alert for Jan 6
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Buy
73
INOD alert for Jan 6
Innodata, Inc. [INOD] is up 4.84% over the past day.
Buy
65
AVAV alert for Jan 6
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
